Does TRT shrink testicles? It can. This is an expected effect of how the hormone system works, not a sign that something went wrong. Testosterone from outside the body tells the brain to turn down the signals that drive the testes. The testes then make less of their own testosterone and do less work. hCG (human chorionic gonadotropin) may support testicular function, but the evidence behind it is small and short-term.

Key takeaways

Why does TRT shrink testicles?

Outside testosterone triggers the body's own brake. The brain senses enough testosterone and turns down the signals that drive the testes. Testes that do less work tend to shrink.

The control system is a feedback loop with three stops:

  1. The hypothalamus, at the base of the brain, releases GnRH (gonadotropin-releasing hormone).
  2. GnRH tells the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone).
  3. LH drives the testes to make testosterone. FSH supports sperm production.

A literature review describes outside testosterone suppressing GnRH and LH release, which results in testicular atrophy and suppressed sperm production (Krzastek et al., 2020). This happens with prescribed replacement, not only with steroid misuse.

The testes have two jobs. Leydig cells make testosterone. The seminiferous tubules are the coiled tubes where sperm are made, and they take up most of the testicular volume. When stimulation falls, both jobs slow down.

The key concept is intratesticular testosterone, meaning testosterone measured inside the testes rather than in blood. In healthy men it is far higher than blood testosterone. That suggests a high local level is needed for normal sperm production (J Clin Endocrinol Metab, 2005). One review calls it an absolute prerequisite for normal sperm production and notes that outside testosterone suppresses it (Crosnoe et al., 2013).

This is why blood testosterone can look normal on TRT while the testes are under-stimulated. The bloodstream gets testosterone from the prescription. The testes get less of their own signal.

Is testicular shrinkage the same as lower fertility?

No. Size is what you notice. Intratesticular testosterone and sperm output are what matter for fertility, and you cannot judge either one by looking or from a standard blood test.

OutcomeWhat it meansHow it is assessedShown by blood testosterone?
Testicular sizePhysical volume of the testesPhysical examNo
Intratesticular testosteroneTestosterone made and held inside the testesMeasured directly only in research studiesNo
Sperm productionNumber and quality of spermSemen analysisNo

The fertility concern is real. The AUA notes that outside testosterone can interrupt sperm production and can lead to severely low or absent sperm counts (AUA, 2018). A 2013 hCG paper opens with the background statement that TRT leads to azoospermia (no sperm in the ejaculate) in 40% of patients. That figure is part of the paper's framing, not a finding of its own study (J Urol, 2013).

The AUA testosterone guideline says testosterone should not be prescribed to men who are currently trying to conceive. It also says clinicians should discuss the long-term impact on sperm production with men interested in future fertility (AUA, 2018). The AUA/ASRM male infertility guideline, amended in 2024, goes further. It says clinicians should not prescribe outside testosterone to men interested in current or future fertility (AUA/ASRM, 2024).

Is the shrinkage permanent? It may not be, but no one can promise full recovery. The studies cited here did not track recovery after testosterone is stopped. Size, the testes' own testosterone production and sperm production are separate recovery outcomes. Don't start, stop or change hormone therapy on your own. Plan any change with your clinician. For recovery and fertility options in depth, see how TRT affects fertility.

How does hCG work on the testes during testosterone therapy?

hCG acts like LH. It stimulates the Leydig cells directly and stands in for the signal that TRT turns down.

The hCG molecule has an alpha subunit that is essentially identical to the alpha subunits of LH, FSH and TSH. Its beta subunit differs (Pregnyl label, FDA, 2023). The AUA/ASRM guideline describes hCG as an LH analogue that stimulates testosterone production directly in the Leydig cells (AUA/ASRM, 2024). It binds the same LH receptors (Krzastek et al., 2020). The pituitary stays quiet, but the testes still receive a working signal.

One direct test of this is the Coviello trial. Healthy men were randomized to testosterone enanthate plus either a saline placebo or low-dose hCG for 3 weeks. The trial enrolled 29 men (J Clin Endocrinol Metab, 2005). In the testosterone-plus-placebo group, intratesticular testosterone fell 94% from baseline (World Journal of Nephrology, 2015). Adding low-dose hCG maintained intratesticular testosterone, and levels rose in line with the hCG dose (J Clin Endocrinol Metab, 2005).

Know the limits before you lean on this trial:

The trial shows a mechanism working in the short term. It does not show long-term protection of size or fertility.

What does the clinical evidence say about hCG with TRT?

Small studies point in a supportive direction, and guidelines allow hCG for men who want to maintain fertility. Whether an hCG add-on reliably preserves fertility is not settled.

The main clinical data comes from Hsieh and colleagues. They retrospectively reviewed the records of men with low testosterone who used testosterone gel or injections together with low-dose hCG. No patient became azoospermic during combined treatment. The authors concluded that hCG "appears to maintain semen parameters" and may preserve fertility, which is tentative wording (J Urol, 2013). A 2025 review lists the series at 26 men (Transl Androl Urol, 2025). Another review notes a mean follow-up of about 6 months and says further study is required (Crosnoe et al., 2013). The series had no comparison group on testosterone alone.

The 2025 review lists testosterone plus hCG as maintaining testicular volume and preserving sperm production, with cost and injections as drawbacks. It also notes that the AUA infertility guideline finds the current evidence for an hCG add-on insufficient to support the approach (Transl Androl Urol, 2025).

The AUA testosterone guideline says clinicians may use aromatase inhibitors, hCG, SERMs (selective estrogen receptor modulators) or a combination in men with testosterone deficiency who want to maintain fertility. Of these, only hCG is FDA-approved for use in males (AUA, 2018). That approval covers specific labeled uses. One example is selected cases of hypogonadotropic hypogonadism, meaning low testosterone caused by pituitary deficiency (Pregnyl label, FDA, 2023). One review notes that hCG is used off-label for testosterone deficiency in men who want to preserve fertility (Krzastek et al., 2020).

EvidenceTypeWhat it measuredWhat it did not show
Coviello trial, 2005Randomized trial, healthy men, 3 weeksIntratesticular testosteroneFertility, pregnancy, testicular size
Hsieh series, 2013Retrospective records review, 26 menSemen parametersPregnancy outcomes, comparison with testosterone alone
AUA and AUA/ASRM guidelinesProfessional-society guidanceRecommendations for practiceProof that an add-on preserves fertility

The honest summary: hCG is biologically plausible and supported by small studies, but the question is not settled. Pages that list hCG doses or promise that hCG will keep size intact claim more than these studies show.

Does every form of TRT cause the same suppression?

Any testosterone from outside the body can suppress the signals that drive the testes. How much suppression a given man sees depends on the dose, the formulation and the individual. That makes it a clinical question.

Guidelines and reviews describe this suppression as an effect of outside testosterone in general, without limiting it to injections (AUA, 2018; Krzastek et al., 2020). Switching to a cream or a capsule is not a reliable way to avoid it.

Some approaches raise the body's own production instead of replacing it. Enclomiphene signals the pituitary to raise LH and FSH, so the testes make more of their own testosterone. Enclomiphene is not an FDA-approved medication. It is used as a compounded medication, and compounded medications are not FDA-approved. Whether it fits your situation is a clinical decision. For a side-by-side comparison, see enclomiphene vs testosterone replacement.

What does a clinician check before adding hCG?

A clinician looks at four things: your goals, your labs and history, whether anything on the hCG label rules it out, and possible side effects.

  1. Goals. Do you want children now, later or never? How much does testicular size matter to you?
  2. Labs and history. Hormone labs show how suppressed your system is. A semen analysis answers a different question than a blood test. See the TRT blood work guide.
  3. Label contraindications. The hCG label lists several. They include prior hypersensitivity to hCG or other gonadotropins and uncontrolled thyroid, adrenal or pituitary disorders. They also include tumors of the hypothalamus or pituitary, and breast or prostate tumors in men (Pregnyl, DailyMed). For prostate context, see does TRT cause prostate cancer.
  4. Side effects. hCG has its own possible side effects, and they belong in the same conversation.

How access works through New Blue

New Blue is a technology and administrative services platform. Medical services are provided by independent licensed clinicians; medications are dispensed only if prescribed.

Every testosterone or hormone pathway, including Testosterone + hCG support, requires a live clinician visit plus lab work. It is not an asynchronous form.

  1. You complete an intake covering your history, symptoms and goals, including your plans for children.
  2. You have a live visit with a licensed clinician, with lab work as part of the evaluation.
  3. The clinician decides whether treatment is appropriate based on your intake and clinical review.
  4. If prescribed, a licensed partner pharmacy ships the medication directly to you. The format is injections. Follow your clinician's guidance and pharmacy instructions.

Not everyone qualifies. Eligibility depends on your intake and clinical review, and that's how it should work. In this pathway, hCG supports testicular function and fertility during testosterone therapy.

Testosterone + hCG support has delivery limits in some states. Availability varies by state, so check state availability first.

Consultation timing varies by clinician availability. If treatment isn't appropriate, refunds follow our refund policy. For current pricing, see the Testosterone + hCG support treatment page. The service is for adults 21 and older and is not for emergencies. New Blue is LegitScript certified.

Frequently Asked Questions

Will hCG stop my testicles from shrinking on TRT?

No one can promise that. In a 3-week trial in healthy men, low-dose hCG maintained testosterone inside the testes during testosterone-induced suppression. A 2025 review lists maintained testicular volume as a feature of testosterone plus hCG. The studies are small, and whether hCG fits your situation is a decision for a licensed clinician.

Can I judge my fertility by testicle size?

No. Testicular size, testosterone inside the testes and sperm production are separate outcomes. A semen analysis measures sperm. A physical exam or a blood testosterone level does not.

Why is my blood testosterone normal if my testes got smaller?

On TRT, blood testosterone comes mostly from the prescription, not from the testes. The therapy turns down GnRH and LH, the brain and pituitary signals that drive the testes. The testes then make less of their own testosterone, even while the blood level sits in range.

Does switching from injections to testosterone cream stop shrinkage?

Not reliably. Any testosterone from outside the body can suppress the signals that drive the testes, and guidelines and reviews do not limit this effect to injections. Changing formulation is a conversation to have with your clinician.

Is hCG a weight-loss treatment?

No. The FDA label for Pregnyl, a brand of hCG, states that hCG has not been shown to be effective additional therapy for obesity. It also says there is no substantial evidence that hCG increases weight loss beyond calorie restriction (Pregnyl label, FDA, 2023).

When should testicle changes on TRT be checked?

Have a new lump, swelling, a marked difference between sides or ongoing discomfort examined rather than assuming TRT caused it. Sudden, severe testicular pain is an emergency and needs in-person emergency care right away.

Does New Blue offer hCG with testosterone therapy?

New Blue offers a Testosterone + hCG support pathway, which requires a live clinician visit plus lab work. If appropriate, a licensed clinician may prescribe it, and not everyone qualifies. It has delivery limits in some states; check state availability.

Sources

  1. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. The Journal of Clinical Endocrinology and Metabolism, 2005. https://pubmed.ncbi.nlm.nih.gov/15713727/
  2. Treatment of hypogonadotropic male hypogonadism: Case-based scenarios. World Journal of Nephrology, 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4419134/
  3. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. The Journal of Urology, 2013. https://pubmed.ncbi.nlm.nih.gov/23260550/
  4. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology, 2018. https://doi.org/10.1016/j.juro.2018.03.115
  5. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; amended 2024). American Urological Association / American Society for Reproductive Medicine, 2024. https://www.auanet.org/documents/Guidelines/PDF/2024%20Guidelines/Male%20Infertility%20Unabridged%20Final.pdf
  6. Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies. Translational Andrology and Urology, 2025. https://doi.org/10.21037/tau-2025-480
  7. Non-testosterone management of male hypogonadism: an examination of the existing literature. Translational Andrology and Urology (Krzastek SC, et al.), 2020. https://tau.amegroups.org/article/view/33647/html
  8. Exogenous testosterone: a preventable cause of male infertility. Translational Andrology and Urology (Crosnoe LE, et al.), 2013. https://tau.amegroups.org/article/view/2249/html
  9. Pregnyl (chorionic gonadotropin) for injection: prescribing information. U.S. Food and Drug Administration (Drugs@FDA), 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017692s028s036s043lbl.pdf
  10. Pregnyl (chorionic gonadotropin) for injection: DailyMed label (contraindications). National Library of Medicine, DailyMed, n.d. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1e94155f-19be-4944-b197-be4edbb4faf9&type=display

Medical disclaimer: This article is educational and is not medical advice. Treatment decisions are made by a licensed clinician based on your history, labs and clinical review. New Blue Health is a technology and administrative services platform, not a medical provider.

Related treatment guide

Related reading

Content review & editorial standards

This page is educational content from the New Blue Health Editorial Team. It is checked under the New Blue Health Content Review Policy and Editorial Policy and should not replace individualized medical advice from a licensed clinician. For how we evaluate evidence, see Evidence Methodology and Clinical Sources & References.

Start Your Visit